Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK

By Beard S. M.   McCrink L.   Le T. K.   Garcia-Cebrian A.   Monz B.   Malik R. A.  

Current Medical Research and Opinion, Vol. 24, Iss. 2, 2008-02 ,pp. : 385-399

Informa Healthcare

Access to resources Recommend Favorite

Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis

By Crucitti Antonio   Zhang Qi   Nilsson Mary   Brecht Stephan   Yang Charles R.   Wernicke Joachim  

Current Medical Research and Opinion, Vol. 26, Iss. 11, 2010-11 ,pp. : 2579-2588

Informa Healthcare

Access to resources Recommend Favorite

Treatment of patients with diabetic peripheral neuropathic pain in China: a double‐blind randomised trial of duloxetine vs. placebo

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 9, 2015-09 ,pp. : 957-966

John Wiley & Sons Inc

Access to resources Recommend Favorite

Changes in opioid use and healthcare costs among U.S. patients with diabetic peripheral neuropathic pain treated with duloxetine compared with other therapies

By Zhao Y.   Wu N.   Chen S.   Boulanger L.   Police R.L.   Fraser K.  

Current Medical Research and Opinion, Vol. 26, Iss. 9, 2010-09 ,pp. : 2147-2156

Informa Healthcare

Access to resources Recommend Favorite

Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain*

By Boulanger Luke   Zhao Yang   Foster Talia S.   Fraser Kimberly   Bledsoe Stacey L.   Russell Mason W.  

Current Medical Research and Opinion, Vol. 25, Iss. 7, 2009-07 ,pp. : 1763-1773

Informa Healthcare

Access to resources Recommend Favorite